A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer (VANISSh)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04024358|
Recruitment Status : Recruiting
First Posted : July 18, 2019
Last Update Posted : July 18, 2019
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer|
|Actual Study Start Date :||January 1, 2015|
|Estimated Primary Completion Date :||January 1, 2025|
|Estimated Study Completion Date :||January 1, 2025|
- PNI and VI correlation with DFS [ Time Frame: Up to 36 months ]Analyze if the severity of perineural and perivascular invasion correlates with disease free survival
- PNI and VI correlation with other clinical variables [ Time Frame: Up to 6 years ]Analyze if the severity of perineural and perivascular invasion correlates with major clinical variables such as early recurrence, site of recurrence, overall survival.
- PNI and VI correlation with neoadjuvant treatment [ Time Frame: Up to 12 months ]Analyze if neoadjuvant treatment impacts the severity of perineural and perivascular invasion.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04024358
|Contact: Giulia Gasparinifirstname.lastname@example.org|
|IRCCS San Raffaele||Recruiting|
|Milan, Italy, 20132|
|Contact: Massimo Falconi, MD 0226436046 email@example.com|
|Principal Investigator:||Marco Schiavo Lena||IRCCS Ospedale San Raffaele|